Unified Trust Company’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$4.62M Buy
28,624
+87
+0.3% +$14.8K 1.36% 31
2021
Q2
$4.7M Buy
28,537
+1,659
+6% +$275K 1.39% 26
2021
Q1
$4.42M Sell
26,878
-131
-0.5% -$21.2K 1.44% 24
2020
Q4
$4.4M Buy
27,009
+692
+3% +$102K 2.55% 15
2020
Q3
$3.92M Sell
26,317
-1,551
-6% -$230K 2.78% 12
2020
Q2
$3.92M Sell
27,868
-9,859
-26% -$1.44M 2.95% 12
2020
Q1
$4.95M Buy
37,727
+204
+0.5% +$28.9K 3.3% 4
2019
Q4
$5.47M Buy
37,523
+148
+0.4% +$20.1K 3.4% 5
2019
Q3
$4.83M Buy
37,375
+143
+0.4% +$18.8K 3.23% 5
2019
Q2
$5.18M Buy
37,232
+1,259
+3% +$174K 3.61% 3
2019
Q1
$5.03M Buy
35,973
+2,721
+8% +$364K 3.77% 2
2018
Q4
$4.29M Buy
+33,252
New +$4.64M 3.9% 2

Other funds holding JNJ

Unified Trust Company's JNJ Position: Q3 2021 in Review

Unified Trust Company increased its Johnson & Johnson (JNJ) stake by 0.3% in Q3 2021, buying an estimated $14.8K and bringing the position to 28,624 shares worth $4.62M. The position accounts for 1.36% of the portfolio, ranked #31.

Unified Trust Company first reported a position in JNJ in Q4 2018 and has held it in 12 quarters since. The position peaked at $5.47M in Q4 2019. 3,312 funds tracked by Wall St. Rank hold JNJ as of Q3 2021.

  • Unified Trust Company held 28,624 shares of Johnson & Johnson worth $4.62M as of Q3 2021.
  • Unified Trust Company bought 87 Johnson & Johnson shares in Q3 2021, an estimated $14.8K.
  • Johnson & Johnson made up 1.36% of Unified Trust Company's portfolio in Q3 2021, its #31 holding.
  • Unified Trust Company first reported a position in Johnson & Johnson in Q4 2018 and has held it in 12 quarters since.
  • Unified Trust Company's Johnson & Johnson position peaked at $5.47M in Q4 2019.
  • 3,312 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2021.

Based on Unified Trust Company's 13F filing for Q3 2021, filed 23 Nov 2021.